In fact, as the sIL-6R levels correlate with the pathogenic effect of IL-6 [20,21,22], the finding that, in FD patients, the levels of sIL-6Rs are consistently higher, as compared to healthy controls, points to its increased activation as a potential mediator of cell and tissue damage in FD. This evidence concerns the gene IL6 and Fabry disease.